Detalles de la búsqueda
1.
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Cancer Sci
; 112(10): 4365-4376, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34252262
2.
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 18(1): 122, 2019 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387585
3.
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.
Int J Cancer
; 144(12): 3099-3110, 2019 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537104
4.
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
J Cell Biochem
; 119(9): 7245-7255, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29797600
5.
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 22(1): 56, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941584
6.
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 16(1): 48, 2017 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28241827
7.
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.
Tumour Biol
; 39(6): 1010428317703924, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28651494
8.
Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.
Dis Markers
; 2022: 8724035, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35548776
9.
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.
Cell Signal
; 59: 152-162, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30926388
10.
BCL9, a coactivator for Wnt/ß-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression.
Oncol Lett
; 11(3): 2001-2008, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26998113
Resultados
1 -
10
de 10
1
Próxima >
>>